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Abstract
Background: Differentiated thyroid cancer (DTC) reports a poorer health-related
quality of life (HRQoL) than a norm population. Patients' illness perceptions are
modifiable and known associates of HRQoL in other cancers. The aim was to
examine the relationship between illness perceptions and HRQoL among DTC
survivors.
Methods: DTC survivors registered in the Netherlands Cancer Registry
diagnosed between 1990 and 2008, received a survey on illness perceptions
(Brief-Illness Perception Questionnaire; B-IPQ) and HRQoL (European
Organisation for Research and Treatment of Cancer, Quality of Life
Questionnaire-Core 30; EORTC QLQ-C30). Multiple regression analyses were
conducted investigating the relation between illness perceptions and HRQoL,
while controlling for sociodemographic and clinical characteristics.
Results: Two hundred and eighty-four DTC survivors were included. DTC
survivors who believed their illness had many negative consequences; who
perceived their illness as controllable by treatment; who had strong beliefs
symptoms could be attributed to their illness; and who had strong beliefs their
illness causes negative emotions, reported a poorer HRQoL.
Conclusions: Stronger negative illness perceptions are related to a poorer
HRQoL among DTC survivors.
KEYWORD S
cancer survivors, differentiated thyroid cancer, health-related quality of life, illness perceptions,
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1 | INTRODUCTION
Thyroid cancer is the most frequent malignancy of the
endocrine system, with the differentiated thyroid cancers
(DTC) papillary and follicular accounting for the majority
of new cases.1 The incidence of DTC is 2.5 times higher in
women than in men,2 and the five-year survival rate is
98.1%.3 The most common treatment of DTC is a total
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thyroidectomy typically followed by radioactive iodine treat-
ment which aims to target remaining malignant thyroid
cells.4 Removal of the thyroid gland results in thyroid
replacement therapy throughout one's entire life.5
Although DTC has a high survival rate and some
studies report HRQoL similar to that of non-cancer
populations,6,7 recent findings show a poorer HRQoL
among DTC survivors compared to other cancers (ie,
breast, prostate, uterine, cervical, colorectal, lung, and
non-Hodgkin lymphoma).8 A previous study of our group
examined HRQoL among long-term DTC survivors and
found that DTC survivors reported significantly worse
levels of physical and psychological functioning, as well
as a significantly higher number of symptoms compared
to a normative population.9,10
Identifying modifiable associates through which HRQoL
of DTC survivors can be improved is an important area of
research. How patients perceive their illness is a known
determinant of HRQoL in various patient groups including
cancer.11-13 These illness perceptions are hypothesized to
influence illness adaptation and outcomes within the struc-
ture of the common-sense self-regulationmodel (SRM) of ill-
ness.14 According to the SRM model, when individuals are
faced with an illness, they form cognitive representations
(beliefs about the illness) and emotional reactions which
together affect both physical and psychosocial outcomes,
principally through coping responses.14
Previous studies among various cancer populations
not including DTC, demonstrated that cancer survivors
with optimistic illness perceptions regarding their prog-
nosis had better health outcomes compared to those with
pessimistic and realistic Illness perceptions.13 Among
various malignancies (breast, prostate, and colorectal
cancer) negative illness perceptions were related to
poorer HRQoL.15,16 Furthermore, previous studies pro-
vide promising evidence for the effectiveness of interven-
tions aimed at helping these individuals acquiring more
adaptive illness perceptions, thereby improving their
HRQoL.17-19 A previous study examining illness percep-
tions among DTC survivors showed that illness percep-
tions were often unrelated to the clinical objective
severity of the disease, and suggested that understanding
and referring to illness perceptions of patients with DTC
is critical as they could strongly impact their perceived
health and HRQoL.20 Previous studies of our group have
shown that illness perceptions are unrelated to medica-
tion adherence21 and function as a mediator for the rela-
tion between information provision and perceived
distress.22 Furthermore, we previously concluded that the
impact of DTC on HRQoL is greater among younger than
older survivors.10 However, to our knowledge the relation
between illness perceptions and HRQoL has never been
examined among DTC survivors. The current study is
therefore the first to examine the relation between illness
perceptions and HRQoL among a sample of mid to
long-term (2-20 years after diagnosis) DTC survivors.
Knowledge on which illness perceptions are associated
with a poor HRQoL is helpful as illness perceptions can
be modified by psychological interventions such as
cognitive-behavioral therapy, which may in turn have
beneficial effects on DTC survivors' HRQoL.
2 | MATERIALS AND METHODS
2.1 | Setting and population
This study is a population-based survey among DTC survi-
vorswho are registeredwithin theNetherlands Cancer Regis-
try (NCR) of the Netherlands Comprehensive Cancer
Organisation. The NCR assembles data of all individuals
recently diagnosedwith cancer in theNetherlands. Every sin-
gle NCR-registered individual diagnosed with DTC between
1990 and 2008 in the Southern part of the Netherlands (2.3
million inhabitants) was qualified to participate in the study
(N = 568). Exclusion criteria were cognitive impairment or
being too ill at the time of the study in order to participate
(N = 31), having unverifiable addresses (N = 90), or having
deceased before the study began (according to the NCR, hos-
pital records, and the Central Bureau for Genealogy, N = 6).
Additionally, one hospital refused to take part in this study
(N = 86). The remaining DTC survivors (N = 355) were
invited to participate in the study.
2.2 | Data collection
In November 2010, data was collected via the Patient
Reported Outcomes Following Initial treatment and Long
term Evaluation of Survivorship (PROFILES) registry.
PROFILES is a registry which facilitates studies examining
the physical and psychosocial impact of cancer as well as
its treatment.23 PROFILES includes an extensive web-
based component which is combined with the clinical data
from the NCR. Data registered in the NCR has been
extracted from medical records by trained registry person-
nel. Internal validation studies are performed evaluating
the quality by randomly checking completeness and
accuracy of the registry personnel extracting information
from the medical records.24 The quality of this data is
high because of thorough training of the registrars and
computerized consistency checks at regional and
national level. Completeness is estimated to be at least
95%.24 PROFILES registry data can be freely used for
noncommercial scientific research, subject to privacy and
confidentiality regulations (www.profilesregistry.nl).
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Details on the data collection have been published
previously.9
Participants who were qualified for the study were
informed by a letter from their (ex-)treating physician.
Within this letter, the goal of the study was explained and
survivors were invited to participate. Additionally, a link
was included to a secure website along with a login name,
and a password through which interested survivors could
grant informed consent and complete the online question-
naires. A paper-and-pencil version of both the informed
consent form and the questionnaire was available for sur-
vivors who preferred that over a digital version. Further-
more, nonrespondents were sent a reminder letter as well
as a paper-and-pencil version of the questionnaire within
2 months after they had initially been invited to do
so. Survivors were guaranteed that there would be no con-
sequences regarding their treatment or follow-up care if
they eventually decided to not participate. This study was
reviewed by the Institutional Review Board and was
deemed nonhuman subjects research.
2.3 | Measurement
2.3.1 | Sociodemographic and clinical
characteristics
The NCR registers sociodemographic (age and gender)
and clinical characteristics (time since diagnosis, tumor
type, cancer stage via TNM classification, and primary
treatment). A questionnaire was used to assess the
sociodemographic variables; marital status, educational
level, and work status. Comorbidity at the time of the
study was assessed with the adapted Self-administered
Comorbidity Questionnaire and included stroke, heart
disease, high blood pressure, lung disease, diabetes, ulcer
or stomach disease, kidney disease, anemia or other
blood disease, depression, osteoarthritis, back pain, and
rheumatoid arthritis.25
2.3.2 | Illness perceptions
The Brief Illness Perception Questionnaire (B-IPQ) was
used to assess the cognitive and emotional perceptions
and illness understanding.26 The single items are rated
on a Likert-scale from 0 to 10, with higher scores indicat-
ing negative illness perceptions. The first five items assess
cognitive perceptions: (a) How much does your illness
affect your life (consequences); (b) How long do you
think your illness will continue (timeline); (c) How much
control do you feel you have over your illness (personal
control); (d) How much do you think your treatment can
help your illness (treatment control); and (e) How much
do you experience symptoms from your illness (identity).
Two items evaluate the emotional perceptions: (f) How
concerned are you about your illness (concern); and,
(g) How much does your illness affect you emotionally
(emotional representation). Finally, one item evaluates
the degree of understanding of the disease: (h) How well
do you understand your illness (disease understanding).
The B-IPQ is of good psychometric quality.26
2.3.3 | Health-related quality of life
HRQoL was measured by the European Organization for
Research and Treatment of Cancer Quality of life
Questionnaire-Core 30-questions (EORTC QLQ-C30).27
This 30-item questionnaire comprises a global QoL scale;
five functioning scales (physical, role, emotional, cogni-
tive, and social); three symptoms scales (fatigue, nausea
and vomiting, and pain), and six single items (dyspnoea,
insomnia, appetite, constipation, diarrhea, and financial
impact). After linear transformation, all scales and single
item measures ranged from 0 to 100 where high scores
on the global QoL and functional scales are indicative of
greater functioning, whereas a high score on the symp-
tom scales means there are more complaints.
2.4 | Statistical analyses
Sociodemographic and clinical characteristics were
calculated using descriptive statistics. Multiple regression
analyses were conducted in order to examine the extent to
which the eight illness perceptions (consequences, timeline,
personal control, treatment control, identity, concern, emo-
tional representation, and disease understanding) were
related to the different HRQoL scales. Multiple regression
analyses were conducted for each HRQoL scale (the five
functioning scales, the three symptom scales, the global qual-
ity of life scale and the six single items) separately. In all ana-
lyses we controlled for sociodemographic (age, sex, marital
status, educational level, and current occupation) and clini-
cal characteristics (time since diagnosis, type of DTC, pri-
mary treatment, and comorbidities), as these factors are
known to be related to illness perceptions and/or HRQoL.
Clinically meaningful effects for the EORTC QLQ-C30
scales were determined using EORTC guidelines, which
were developed by a systematic review of 152 cancer-
specific articles, expert opinions, and meta-analyses.28
These EORTC guidelines classifies four effects: Trivial,
circumstances unlikely to have any clinical relevance or
where there was no difference; Small, subtle but neverthe-
less clinically relevant; Medium, likely to be clinically
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relevant but to a lesser extent; Large, one representing
unequivocal clinical relevance.28 As we performed multiple
tests, we chose a significant level of 1% as our hypotheses
were theory driven and this is the first study relating illness
perceptions to HRQoL among DTC survivors. Analyses
were performed using IBM SPSS version 24.0 (Statistical
Package for Social Sciences, Chicago, Illinois).
3 | RESULTS
3.1 | Sociodemographic and clinical
characteristics
Of the total 334 DTC survivors, 285 survivors successfully
completed the questionnaire (response rate = 85%). As
one participant was excluded due to traceability, a total
of 284 DTC survivors were included. There were no dif-
ferences on sociodemographic or clinical characteristics,
when comparing respondents to nonrespondents.22 The
majority of participants were female (76.4%), and the
most common type of DTC was papillary (76.1%). A full
description of sociodemographic and clinical characteris-
tics is provided in Table 1.
3.2 | Illness perceptions and
health-related quality of life
Table 2 provides the mean scores and standard deviations
for illness perceptions and HRQoL. DTC survivors hold
the strongest negative perception for the item timeline
(mean of 6.74, SD = 3.79), with higher scores indicate
that DTC survivors believe their illness will continue for
a long time. The least negative perceptions were for treat-
ment control (mean = 3.38, SD = 2.63), with low scores
indicating that DTC survivors believe treatment is very
helpful, and emotional perceptions (mean of 3.38,
SD = 2.56), where low scores indicate that DTC survivors
are to some extent emotionally affected by their illness.
With respect to HRQoL, survivors reported the highest
score on social functioning (mean = 85.43, SD = 24.62), and
lowest on global QoL (mean = 75.95, SD = 20.19). As for the
symptoms, most often reported were fatigue (mean = 28.10,
SD = 25.02), and insomnia (mean 21.82, SD = 29.22).
3.3 | The relationship between illness
perceptions and health-related quality
of life
DTC survivors with stronger beliefs their illness
affected their lives (consequences) reported poorer
global QoL (B = −1.95), physical (B = −1.97), role
(B = −3.03), and social (B = −2.31) functioning,
whereas more fatigue (B = 3.13), and pain (B = 2.59),
Table 3. A stronger belief the illness could be managed





Sex (male) 67 (23.6)
Mean age at time of survey 55.98 (14.12)
Marital status
Married/cohabiting 224 (78.9)
Divorced/widowed/never married 60 (21.1)
Educational levela
Lower education 30 (10.6)
Medium education 177 (62.3)





















Surgery alone 67 (23.6)
Surgery + ablation 207 (72.9)
Surgery + radiotherapy 8 (2.8)
Other 2 (0.7)




Note: Part of this table has been previously published.22
aEducation level: low (primary school or no education), medium
(lower general secondary education or vocational training),
and high (high vocational training or university level).
bWork status: unemployed also includes students, retired individ-
uals, housewives, and so forth.
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by treatment (treatment control) was significantly related to
lower global HRQoL (B = −1.67), and physical functioning
(B = 1.29). DTC survivors who reported experiencing more
symptoms as a result of their illness (identity), reported
poorer social functioning (B = −1.83), more fatigue
(B = 2.15), insomnia (B = 2.50), constipation (B = 1.55),
and experienced a negative financial impact of their illness
(B = 1.95). Survivors who were affected by their illness
(emotional representations) reported poorer global QoL
(B = −1.74), and poorer social functioning (B = −2.07). All
significant associations were of trivial clinical importance
according to the EORTC guidelines.28
Overall, in addition to the associations with illness
perceptions, the following covariates were significantly
related to HRQoL and of small clinical relevance. DTC
survivors of older age reported poorer role functioning,
whereas females reported less financial difficulties. Those
who were not married or living together reported more
problems of constipation. An increasing number of co-
morbidities was related to poorer global QoL, and physi-
cal functioning, and more pain. No significant relations
were found for the remaining sociodemographic or clini-
cal covariates.
4 | DISCUSSION
The main finding of this study is that DTC survivors
holding stronger beliefs their illness affects their live
(consequences); their illness can be controlled by treat-
ment (treatment control); they are emotionally affected
by their illness (emotional representation) report a
poorer HRQoL, independent of sociodemographic and
clinical characteristics. Specifically, our study showed
that DTC survivors who belief their life is negatively
affected by their illness (consequences) report poorer
global QoL, physical, role, and social functioning,
whereas they report more fatigue, and pain. Further-
more, DTC survivors who belief their illness can be con-
trolled by treatment (treatment control) report a poorer
global QoL, and lower scores on physical functioning.
Those DTC survivors who attribute many symptoms to
their illness (identity) report more fatigue, insomnia,
and a larger financial impact. DTC survivors who report
to be more emotionally affected by their illness (emo-
tional representations) report a poorer global QoL, and
social functioning.
Although the majority of our findings are in line with
previous studies29-31; we surprisingly found that contrary
to studies among other cancer survivors, DTC survivors
with a strong belief treatment could control their illness
reported a poorer global QoL, and physical functioning.
This negative association may be explained as followed.
DTC survivors need life-long thyroid replacement therapy
after being treated with a total thyroidectomy. In prepara-
tion of follow-up scans examining thyroid cancer recur-
rence, thyroid treatment is stopped. During this
withdrawal period, hypothyroidism may occur which has
known negative impacts on HRQoL.32 Moreover, even
while on constant and adequate dosage of thyroid replace-
ment therapy, many side effects negatively impacting
HRQoL are known among non-cancer populations.33
However, studies report that—while having clinically
TABLE 2 Mean scores for illness perceptions and





Personal control 5.41 3.14
Treatment control 3.38 2.63
Identity 4.07 2.79
Concern 3.79 2.55
Emotional representation 3.38 2.56
Illness understanding 3.51 2.60
Health-related quality of life
Global QoL 75.95 20.19
Functioning
Role functioning 82.43 26.47
Physical functioning 83.50 19.01
Cognitive functioning 82.18 22.28
Social functioning 85.43 24.62










Financial impact 9.35 21.39
Note: Scores for illness perceptions range on a scale from 0 to 10, with
higher scores indicating stronger negative perceptions. HRQoL-scales
and single item measures ranged from 0 to 100 where high scores on
global QoL and the functional scales are indicative of greater function-
ing, whereas a high score on the symptom scales means there are more
complaints.
Abbreviation: QoL, quality of life
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adequate blood levels—non-cancer populations suffering
from thyroid disease who had a total thyroidectomy have
better HRQoL levels compared to those without previous
surgery who solely receive hormone replacement ther-
apy.34,35 Noteworthy, health care professionals acknowl-
edge and underscore the difficulty of attributing symptoms
to thyroid disease when with hormones-treated patient's
clinical blood levels are within range.36 Extra caution is
therefore warranted when administering patients' addi-
tional thyroid hormones, just in case symptom are from
their thyroid disease.36
Interestingly, disease understanding was unrelated
to HRQoL in our DTC survivors, although previous
studies among other patient populations have also
reported nonsignificant findings.17,29 A former study
among DTC patients revealed that a higher level of dis-
ease understanding was associated however with less
negative emotional perceptions.20 This suggests that dis-
ease understanding maybe indirectly related to HRQoL
through negative emotional perceptions. Indeed, in a
study conducted by our own group we found that
greater information support was associated with better
illness perceptions, and that better illness perceptions
were associated with less distress.22
The findings of our study showed that negative Illness
perceptions are related to poorer HRQoL among DTC
survivors. As a result, DTC survivors' HRQoL may be
improved by changing these negative illness perceptions.
A previous study by our group has shown that better
information provision was associated with more positive
illness perceptions among various cancer survivors.22
This relation was not limited to illness understanding but
also related to cognitive and emotional perceptions.37 It
is key that the provided information is tailored to the
individual patient. However, as a previous study among
gynecological cancer survivors has shown that providing
extensive information in the form of a cancer survivor-
ship plan can result in poorer illness perceptions.38
4.1 | Clinical implications
Prior studies have suggested that sense of coherence
(SOC) may be a pathway, mediating the relation between
illness perceptions and HRQoL,39 as patients with a
strong SOC define their illness as comprehensible, man-
ageable and meaningful.40 Improving DTC survivors SOC
can therefore help them with being less emotionally
affected by their illness, developing more appropriate
cognitions and acquiring a higher understanding of their
illness, and therefore improving their HRQoL. Although
interesting, research into the role of SOC within the con-
text of HRQoL has exclusively focused on congenital
heart disease, therefore further research would be needed
to examine its effect among DTC survivors.
Psychological interventions such as cognitive-
behavioral therapy may also help DTC survivors with
having less negative beliefs about the potential conse-
quences of their illness and therefore reduce certain neg-
ative emotions (by improving emotional illness
perceptions) and improve their cognitions. Indeed, a
review among patients with cardiovascular disease shows
that cognitive-behavioral therapy together with education
and counseling are beneficial in changing illness percep-
tions.17 Among cancer survivors, studies have shown
comparable results. A study found that positive changes
in illness perceptions improved emotional well-being
among breast cancer patients who took part in a psycho-
social aftercare program.18 Similarly, a previous study
found that changes in illness perceptions (especially by
increasing the belief of control) was related to positive
changes in psychological well-being over time within a
sample of esophageal cancer survivors.19 Accordingly, the
aforementioned studies provide promising evidence for
the effectiveness of interventions aimed at helping indi-
viduals acquiring more adaptive illness perceptions,
thereby improving their HRQoL. However, there are cur-
rently no studies looking into the effectiveness of illness
perception interventions among DTC survivors, therefore
future research within this specific population is
warranted. Reforming illness perceptions may not only
be beneficial for DTC survivors' HRQoL, but may also
stimulate adequate health-behaviors such as medication
adherence.41 This is an important aspect of after-care
among DTC survivors as most depend on life-long thy-
roid replacement therapy.
4.2 | Limitations and strengths
Results of this study should be interpreted while keeping
in mind the following limitations. We included DTC sur-
vivors (2-20 years after diagnosis), therefore we intro-
duced survivorship bias to our sample. We know a poorer
HRQoL is a predictor of survival,42 hence those DTC sur-
vivors with poorer HRQoL could be underrepresented as
they might have deceased prior to the study. Further-
more, our results showed that thyroid cancer survivors of
older age, being female and having co-morbid conditions
reported a poorer HRQoL, although of small clinical sig-
nificance. Respondents vs nonrespondents however
showed no statistical differences in sociodemographic or
clinical characteristics, therefore the impact seems to be
limited. The cross-sectional study design prohibits us
from making causal inferences. Although our analyses do
indeed imply a significant yet trivial relation between
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variables, cause-and-effect cannot be determined, mean-
ing that illness perceptions and HRQoL may have a
reciprocal relationship. Furthermore, other factors that
are not included in this secondary data analysis, such as
Type D personality43 or psychological functioning7 are also
related to HRQoL. Although inclusion of many other fac-
tors may improve the model explaining variation in
HRQoL, knowledge on changeable determinants like illness
perceptions are most valuable when it comes to improving
patient-outcomes like HRQoL. Our study also contains sev-
eral strengths, as this is the first study relating illness per-
ceptions to HRQoL among DTC survivors. Furthermore,
our study has a high response rate (85%), large sample size
(N = 284), and included sociodemographic and clinical
characteristics as covariates in the analyses to correct for
potential confounding. Moreover, we included survivors
who were diagnosed 2 to 20 years ago, representing mid to
long-term survivors. The effect of survivorship bias seems
limited as the majority of DTC patients have a good
survival rate.
4.3 | Conclusion
DTC survivors with negative emotional and cognitive
perceptions about their illness report poorer HRQoL
independent of sociodemographic and clinical charac-
teristics. In detail, negative emotional and cognitive
perceptions were associated with poorer global, emo-
tional and social functioning, and more symptoms of
fatigue, nausea and vomiting, pain, dyspnoea, insom-
nia, appetite loss, and constipation. Interestingly, dis-
ease understanding was not related to any of the
HRQoL scales. The negative effects of DTC on HRQoL
may be affected by poor illness perceptions. This
knowledge is therefore helpful in identifying DTC sur-
vivors at risk of experiencing a poor HRQoL, and given
the modifiable nature of illness perceptions, it provides
a possibility for improving them by means of psycho-
logical interventions.
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